WVE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 31.10%

Insider Buying (Last 12 Months): $5,000,000.00

Insider Selling (Last 12 Months): $272,481.60

Wave Life Sciences Insider Trading History Chart

Wave Life Sciences Share Price & Price History

^$4.74

▼ -0.27 (-5.39%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

Wave Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/3/2024	Kyle Moran	CFO	Sell	15,630	$6.17	$96,437.10	33,921
12/11/2023	Ra Capital Management, L.P.	Director	Buy	1,000,000	$5.00	$5,000,000.00	19,202,009
8/23/2023	Kyle Moran	CFO	Sell	37,062	$4.75	$176,044.50	46,120
2/16/2023	Chandra Vargeese	Insider	Sell	10,249	$4.03	$41,303.47	106,624
2/16/2023	Kyle Moran	CFO	Sell	9,729	$4.04	$39,305.16	79,751
2/16/2023	Paul Bolno	CEO	Sell	29,400	$4.04	$118,776.00	407,425
6/16/2022	Ra Capital Management, L.P.	Director	Buy	9,480,052	$2.15	$20,382,111.80	17,202,009
5/5/2022	Chandra Vargeese	Insider	Sell	16,714	$1.72	$28,748.08	111,095
5/5/2022	Kyle Moran	CFO	Sell	5,021	$1.72	$8,636.12	84,567
5/5/2022	Paul Bolno	CEO	Sell	33,501	$1.72	$57,621.72	436,825
2/16/2022	Chandra Vargeese	CTO	Sell	10,603	$2.32	$24,598.96
2/16/2022	Chris Francis	Insider	Sell	10,123	$2.31	$23,384.13
2/16/2022	Kyle Moran	CFO	Sell	9,204	$2.31	$21,261.24
2/16/2022	Paul Bolno	CEO	Sell	33,150	$2.32	$76,908.00

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

SEC Filings (Institutional Ownership Changes) for Wave Life Sciences (NASDAQ:WVE)

89.73% of Wave Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Wave Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/5/2024	Wellington Management Group LLP	274,093	$1.38M	0.0%	+3.5%	0.277%
2/26/2024	Virtu Financial LLC	34,432	$0.17M	0.0%	N/A	0.035%
2/16/2024	Public Employees Retirement System of Ohio	12,600	$64K	0.0%	N/A	0.013%
2/15/2024	Birchview Capital LP	40,000	$0.20M	0.2%	N/A	0.040%
2/14/2024	Platinum Investment Management Ltd.	655,331	$3.31M	0.1%	+43.9%	0.662%
2/13/2024	Tower Research Capital LLC TRC	11,335	$57K	0.0%	+461.4%	0.011%
2/13/2024	James J. Burns & Company LLC	65,049	$0.33M	0.1%	+96.8%	0.066%
2/12/2024	Capstone Investment Advisors LLC	50,000	$0.25M	0.0%	N/A	0.050%
2/12/2024	Monashee Investment Management LLC	103,300	$0.52M	0.1%	N/A	0.104%
2/12/2024	M28 Capital Management LP	7,373,413	$37.24M	30.8%	+4.7%	7.444%
2/12/2024	TD Asset Management Inc	205,746	$1.04M	0.0%	+26.5%	0.208%
2/9/2024	Primecap Management Co. CA	3,759,408	$18.99M	0.0%	-0.6%	3.795%
2/9/2024	Oxford Asset Management LLP	10,045	$51K	0.1%	N/A	0.010%
2/9/2024	Trexquant Investment LP	32,119	$0.16M	0.0%	N/A	0.032%
2/7/2024	Teacher Retirement System of Texas	17,105	$86K	0.0%	N/A	0.017%
2/6/2024	Swiss National Bank	152,400	$0.77M	0.0%	N/A	0.154%
2/6/2024	a16z Perennial Management L.P.	77,619	$0.39M	0.1%	N/A	0.078%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	32,250	$0.16M	0.0%	+1,512.5%	0.033%
1/30/2024	Strs Ohio	75,800	$0.38M	0.0%	N/A	0.077%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	35,523	$0.18M	0.0%	-59.0%	0.036%
1/24/2024	Arizona State Retirement System	17,943	$91K	0.0%	N/A	0.018%
1/24/2024	China Universal Asset Management Co. Ltd.	11,456	$58K	0.0%	+351.7%	0.012%
1/12/2024	SG Americas Securities LLC	34,562	$0.18M	0.0%	+33.6%	0.035%
1/12/2024	Kraematon Investment Advisors Inc.	47,000	$0.24M	0.3%	N/A	0.047%
12/1/2023	Wellington Management Group LLP	264,885	$1.52M	0.0%	+4.3%	0.267%
11/15/2023	Kynam Capital Management LP	3,932,082	$22.61M	3.7%	+0.2%	3.970%
11/15/2023	Laurion Capital Management LP	871,500	$5.01M	0.0%	+5.1%	0.880%
11/15/2023	Adage Capital Partners GP L.L.C.	3,787,730	$21.78M	0.0%	-18.0%	3.824%
11/14/2023	683 Capital Management LLC	5,850,000	$33.64M	2.6%	-3.0%	5.906%
11/14/2023	Newtyn Management LLC	510,000	$2.93M	0.7%	+2.0%	0.515%
11/14/2023	Primecap Management Co. CA	3,780,508	$21.74M	0.0%	-0.8%	3.817%
11/13/2023	M28 Capital Management LP	7,044,500	$40.51M	46.4%	-0.1%	7.112%
11/13/2023	FMR LLC	660,425	$3.80M	0.0%	-14.7%	0.667%
11/7/2023	New York State Common Retirement Fund	7,923	$46K	0.0%	-67.7%	0.008%
11/7/2023	James J. Burns & Company LLC	33,049	$0.19M	0.1%	+10.2%	0.033%
11/7/2023	Jump Financial LLC	23,545	$0.14M	0.0%	N/A	0.024%
10/27/2023	TD Asset Management Inc	162,692	$0.94M	0.0%	N/A	0.164%
10/26/2023	Clear Harbor Asset Management LLC	14,000	$80K	0.0%	-60.8%	0.014%
10/26/2023	Chicago Partners Investment Group LLC	11,136	$60K	0.0%	-40.8%	0.011%
10/13/2023	SG Americas Securities LLC	25,868	$0.15M	0.0%	N/A	0.026%
9/21/2023	Barclays PLC	18,837	$69K	0.0%	-39.9%	0.019%
8/15/2023	Kynam Capital Management LP	3,924,602	$14.29M	2.0%	+3.1%	3.965%
8/14/2023	683 Capital Management LLC	6,031,000	$21.95M	1.6%	+0.5%	6.093%
8/11/2023	M28 Capital Management LP	7,050,000	$25.66M	33.9%	+1.4%	7.123%
8/11/2023	Artal Group S.A.	2,870,523	$10.45M	0.3%	-4.3%	2.900%
8/8/2023	Chicago Partners Investment Group LLC	18,799	$82K	0.0%	-33.3%	0.019%
8/4/2023	American International Group Inc.	28,459	$0.10M	0.0%	N/A	0.029%
7/27/2023	James J. Burns & Company LLC	30,000	$0.11M	0.0%	N/A	0.030%
7/21/2023	Clear Harbor Asset Management LLC	35,700	$0.13M	0.0%	N/A	0.036%
5/15/2023	Maverick Capital Ltd.	6,596,778	$28.56M	0.7%	-7.1%	6.706%
5/12/2023	Platinum Investment Management Ltd.	455,331	$1.97M	0.1%	+32.4%	0.463%
5/9/2023	Y Intercept Hong Kong Ltd	21,667	$94K	0.0%	N/A	0.022%
4/26/2023	Chicago Partners Investment Group LLC	28,168	$0.11M	0.0%	+25.9%	0.029%
2/14/2023	683 Capital Management LLC	6,000,000	$42M	3.6%	-21.3%	6.904%
2/14/2023	Dorsey Wright & Associates	4,400	$31K	0.0%	N/A	0.005%
2/13/2023	Platinum Investment Management Ltd.	343,955	$2.41M	0.1%	-42.5%	0.396%
2/13/2023	Gyon Technologies Capital Management LP	10,626	$74K	0.0%	N/A	0.012%
2/10/2023	M28 Capital Management LP	5,903,405	$41.32M	39.4%	-26.0%	6.793%
2/9/2023	Citigroup Inc.	159,766	$1.12M	0.0%	+1,554.2%	0.184%
2/1/2023	DekaBank Deutsche Girozentrale	35,000	$0.24M	0.0%	N/A	0.040%
1/24/2023	Matisse Capital	12,213	$85K	0.1%	N/A	0.014%
1/20/2023	Matisse Capital	12,213	$85K	0.1%	N/A	0.014%
11/15/2022	Platinum Investment Management Ltd.	598,612	$2.16M	0.1%	-47.3%	0.689%
11/15/2022	Primecap Management Co. CA	4,409,908	$15.92M	0.0%	-0.4%	5.075%
11/15/2022	Kynam Capital Management LP	1,397,479	$5.05M	1.1%	-17.6%	1.608%
11/15/2022	Caxton Associates LP	24,013	$87K	0.0%	N/A	0.028%
11/14/2022	683 Capital Management LLC	7,622,348	$27.52M	2.1%	+1.3%	8.779%
11/14/2022	Point72 Asset Management L.P.	1,034,200	$3.73M	0.0%	N/A	1.191%
11/14/2022	Ergoteles LLC	164,308	$0.59M	0.0%	-16.0%	0.189%
8/16/2022	DAFNA Capital Management LLC	372,361	$1.21M	0.3%	-4.6%	0.608%
8/15/2022	Laurion Capital Management LP	871,500	$2.83M	0.0%	N/A	1.423%
8/12/2022	Ikarian Capital LLC	98,039	$0.32M	0.1%	-90.6%	0.160%
8/11/2022	Primecap Management Co. CA	4,426,808	$14.39M	0.0%	-2.9%	7.228%
8/11/2022	Artal Group S.A.	3,000,000	$9.75M	0.5%	+200.0%	4.898%
8/11/2022	Platinum Investment Management Ltd.	1,135,348	$3.69M	0.1%	-15.0%	1.854%
8/8/2022	Y Intercept Hong Kong Ltd	11,295	$37K	0.0%	N/A	0.018%
5/13/2022	Kynam Capital Management LP	1,911,728	$3.82M	1.2%	+27.9%	3.141%
5/13/2022	M28 Capital Management LP	5,850,000	$11.70M	10.8%	+55.4%	9.612%
5/12/2022	Gyon Technologies Capital Management LP	24,567	$49K	0.0%	+97.2%	0.040%
5/11/2022	Primecap Management Co. CA	4,561,275	$9.12M	0.0%	-0.7%	7.495%
5/11/2022	GSA Capital Partners LLP	196,887	$0.39M	0.1%	+13.4%	0.324%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	169,432	$0.34M	0.0%	-8.4%	0.278%
4/29/2022	SG Americas Securities LLC	486,048	$0.97M	0.0%	-40.5%	0.799%
2/15/2022	683 Capital Management LLC	187,128	$0.59M	0.0%	-66.8%	0.318%
2/15/2022	Adage Capital Partners GP L.L.C.	450,000	$1.41M	0.0%	+12.5%	0.765%
2/14/2022	Deerfield Management Company L.P. Series C	552,690	$1.74M	0.0%	-82.8%	0.939%
2/14/2022	DAFNA Capital Management LLC	390,161	$1.23M	0.3%	N/A	0.663%
2/14/2022	Maverick Capital Ltd.	5,593,389	$17.56M	0.2%	+75.2%	9.507%
2/14/2022	GSA Capital Partners LLP	173,645	$0.55M	0.1%	+429.9%	0.295%
2/11/2022	Primecap Management Co. CA	4,594,575	$14.43M	0.0%	+0.6%	7.810%
2/11/2022	M28 Capital Management LP	3,765,588	$11.82M	9.2%	N/A	6.400%
2/10/2022	Bellevue Group AG	4,602,858	$14.45M	0.1%	+76.8%	7.824%
2/10/2022	Campbell & CO Investment Adviser LLC	27,100	$85K	0.0%	N/A	0.046%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	185,012	$0.58M	0.0%	+32.6%	0.314%
2/8/2022	Northern Trust Corp	415,366	$1.30M	0.0%	+10.9%	0.706%
2/7/2022	SG Americas Securities LLC	816,738	$2.57M	0.0%	+650.6%	1.388%
1/21/2022	Russell Investments Group Ltd.	16,210	$50K	0.0%	-25.2%	0.028%
11/16/2021	Squarepoint Ops LLC	20,080	$98K	0.0%	-41.8%	0.040%
11/16/2021	Maverick Capital Ltd.	3,193,389	$15.65M	0.2%	+3.4%	6.290%
11/16/2021	Millennium Management LLC	1,081,864	$5.30M	0.0%	-14.2%	2.131%

Data available starting January 2016

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Today's Range

Now: $4.74

$4.73

$4.92

50 Day Range

MA: $5.53

$3.91

$6.84

52 Week Range

Now: $4.74

$3.15

$7.67

Volume

397,715 shs

Average Volume

840,445 shs

Market Capitalization

$579.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Wave Life Sciences?: Wave Life Sciences' top insider shareholders include:
Ra Capital Management, LP (Director)
Paul Bolno (CEO)
Chandra Vargeese (Insider)
Kyle Moran (CFO)
Learn More about top insider investors at Wave Life Sciences.